Bausch-Lomb Incorporated

Spectronics Corporation

Jennifer Marie Hunt

Ivan M Nunez

Jeffrey George Linhardt

Joseph A McGee

Michele Alton

Jay Friedrich Kunzler

John Thomas Duerr

Ivan M Nuñez

Limin Chen

Lynn Coullard

Devon A Shipp

Analuz Mark

Drazen Pavlovic

Jonathan Daniel Cooper

Daniel M Ammon, Jr

Robert B Steffen

Vicki Barniak

Daniel J Hook

Keyla M Cubi

Analuz Changano

Ivan M NUÑEZ

Daniel M Ammon

Joseph A Mcgee

A packaging system for the storage of an ophthalmic device is disclosed. The packaging system comprises a sealed container containing one or more unused ophthalmic devices immersed in an aqueous packaging solution comprising one or more hydrophilic polymers or copolymers comprising hydrophilic units and endcapped with a hydrophobic end group and a hydrophilic end group, wherein the solution has an osmolality of at least about 200 mOsm/kg, a pH of about 6 to about 9 and is heat sterilized.

Contact lens packaging solutions containing hydrophilic polymers endcapped with a hydrophilic and a hydrophobic group

Provided is a porous pellet for inclusion into an operating fluid of a fluid system for detecting sites of fluid leakage. The porous pellet comprises a solid matrix formed by at least one fluorescent dye which is solid at room temperature. The matrix has a porosity of from about 10% to about 90%. Methods of installing the porous pellets into fluid system for detection of leaks is also provided.

Fluorescent dye formulation and leak detection method

An ophthalmic device is disclosed that is a polymerization product of a monomeric mixture comprising: (a) a major amount of one or more non-silicone-containing hydrophilic monomers; (b) a crosslinking agent mixture comprising (i) one or more first crosslinking agents containing at least two ethylenically unsaturated reactive end groups, wherein the at least two ethylenically unsaturated reactive end groups are (meth)acrylate-containing reactive end groups and (ii) one or more second crosslinking agents containing at least two ethylenically unsaturated reactive end groups wherein at least one of the ethylenically unsaturated reactive end groups is a non-(meth)acrylate reactive end group, and (c) one or more hydrophilic polymers or copolymers comprising one or more hydrophilic units and a thio carbonyl thio fragment of a reversible addition fragmentation chain transfer ('RAFT') agent wherein the ophthalmic device has an equilibrium water content of at least about 45 weight percent.

Ophthalmic devices

Biomedical devices such as contact lenses formed from a polymerization product of a mixture comprising (a) a multi-armed macromonomer comprising multiple side chains attached to a nucleus, wherein each side chain comprises a thio carbonyl thio fragment of the same or different reversible addition fragmentation chain transfer ('RAFT') agent; and (b) one or more biomedical device-forming monomers are disclosed.

Biomedical devices

A substantially fully copolymerized UV blocking hydrogel lens demonstrating sufficient blocking of UV light to meet at least FDA Class II specifications for UV blocking formed from a reaction mixture comprising at least NVP and one other comonomer and a free-radical polymerizable, substituted or unsubstituted, Bis O-hydroxy benzophenone is provided herein.

Fully polymerized UV blocking silicone hydrogel lens

A method of preparing a water extractable silicon-containing biomedical device is disclosed. The method involves curing a monomer mixture comprising one or more silicon-containing biomedical device-forming monomers in the presence of a diluent to produce a silicon-containing biomedical device; wherein the diluent comprises a boric acid ester of a Cto Cmonohydric alcohol.

Method of preparing water extractable silicon-containing biomedical devices

Biomedical devices such as silicone hydrogels formed from a polymerization product of a mixture comprising (a) a siloxane-containing homopolymer which has only one thio carbonyl thio fragment of a reversible addition fragmentation chain transfer (RAFT) agent; and (b) one or more biomedical device-forming comonomers are disclosed.

Biomedical devices such as silicone hydrogels formed from a polymerization product of a mixture comprising (a) a siloxane-containing homopolymer comprising one or more thio carbonyl thio fragments of a reversible addition fragmentation chain transfer (RAFT) agent; and (b) one or more biomedical device-forming monomers are disclosed.

Growing community of inventors

Lake Grove, NY, United States of America

Jennifer Marie Hunt